Viracta Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Viracta Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Viracta Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 11, 2024 was 39.7M shares, a 2.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 39.7M +1.12M +2.9% Nov 11, 2024 10-Q 2024-11-13
Q2 2024 39.4M +837K +2.17% Aug 5, 2024 10-Q 2024-08-14
Q1 2024 39.3M +861K +2.24% Mar 4, 2024 10-K 2024-03-07
Q3 2023 38.6M +427K +1.12% Nov 6, 2023 10-Q 2023-11-09
Q2 2023 38.6M +1.02M +2.72% Aug 4, 2023 10-Q 2023-08-14
Q1 2023 38.4M +925K +2.47% Mar 6, 2023 10-K 2023-03-14
Q3 2022 38.2M +886K +2.37% Nov 1, 2022 10-Q 2022-11-10
Q2 2022 37.6M +332K +0.89% Aug 1, 2022 10-Q 2022-08-09
Q1 2022 37.5M +443K +1.2% Mar 4, 2022 10-K 2022-03-17
Q3 2021 37.3M +19.2M +106% Nov 3, 2021 10-Q 2021-11-10
Q2 2021 37.2M -144M -79.4% Aug 2, 2021 10-Q 2021-08-12
Q1 2021 37M -74.3M -66.7% May 7, 2021 10-Q 2021-05-13
Q3 2020 18.1M -93.2M -83.7% Nov 11, 2020 10-Q 2020-11-16
Q2 2020 181M +69.6M +62.5% Aug 6, 2020 10-Q 2020-08-11
Q1 2020 111M +43.8M +64.8% Mar 4, 2020 10-K 2020-03-10
Q3 2019 111M +73.9M +197% Nov 5, 2019 10-Q 2019-11-12
Q2 2019 111M +75.2M +208% Aug 1, 2019 10-Q 2019-08-07
Q1 2019 67.6M +33.2M +96.7% Mar 1, 2019 10-K 2019-03-07
Q3 2018 37.4M +3.17M +9.27% Oct 31, 2018 10-Q 2018-11-05
Q2 2018 36.1M +12.6M +53.7% Aug 2, 2018 10-Q 2018-08-08
Q1 2018 34.3M +12.9M +60.1% Mar 1, 2018 10-K 2018-03-09
Q3 2017 34.2M +13.4M +64% Oct 27, 2017 10-Q 2017-11-02
Q2 2017 23.5M -63.5M -73% Jul 21, 2017 10-Q 2017-07-27
Q1 2017 21.5M -65.5M -75.3% Apr 28, 2017 10-Q 2017-05-08
Q3 2016 20.9M -54.6M -72.3% Oct 24, 2016 10-Q 2016-11-03
Q2 2016 87M +11.5M +15.3% Jul 22, 2016 10-Q 2016-07-29
Q1 2016 86.9M +14M +19.2% Apr 30, 2016 10-Q 2016-05-09
Q3 2015 75.5M +13.5M +21.8% Oct 30, 2015 10-Q 2015-11-05
Q2 2015 75.5M +15M +24.9% Jul 30, 2015 10-Q 2015-07-30
Q1 2015 73M +12.9M +21.4% Apr 30, 2015 10-Q 2015-05-05
Q3 2014 61.9M +7.97M +14.8% Oct 31, 2014 10-Q 2014-11-10
Q2 2014 60.4M +8.75M +16.9% Jul 25, 2014 10-Q 2014-08-05
Q1 2014 60.1M +8.49M +16.4% Mar 4, 2014 10-K 2014-03-06
Q3 2013 54M +2.48M +4.82% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 51.7M +4.59M +9.74% Jul 31, 2013 10-Q 2013-08-02
Q1 2013 51.6M +4.68M +9.98% Apr 30, 2013 10-Q 2013-05-09
Q3 2012 51.5M +4.79M +10.2% Oct 31, 2012 10-Q 2012-11-08
Q2 2012 47.1M +391K +0.84% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 46.9M Apr 30, 2012 10-Q 2012-05-15
Q3 2011 46.7M Oct 31, 2011 10-Q 2011-11-14
Q2 2011 46.7M Jul 31, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.